Under the agreement Medtronic will act as the exclusive sales agent of MagnetOs for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeries, according to a Jan. 7 news release. Kuros Biosciences, which is behind MagnetOs, will support Medtronic’s sales team and be responsible for contracts and partnerships.
MagnetOs bone grafts use NeedleGrip surface technology to aid bone growth in soft issues and a more predictable spinal fusion.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
